Development of a highly sensitive digital PCR assay to quantify long non-coding RNA MYU in urine samples which exhibited great potential as an alternative diagnostic biomarker for prostate cancer

BACKGROUND: The diagnostic methods of prostate cancer (PCa) present major drawbacks in that serum prostate specific antigen (PSA) testing lacks specificity for PCa and prostate needle biopsy is a painful and highly invasive procedure for patients. Thus, new alternative screening methods which are sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Di, Yin, Huming, Wang, Yong, Cao, Yang, Yin, Jian, Zhang, Jianping, Yin, Huancai, Zhao, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575588/
https://www.ncbi.nlm.nih.gov/pubmed/34804824
http://dx.doi.org/10.21037/tau-21-820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575588/
https://www.ncbi.nlm.nih.gov/pubmed/34804824
http://dx.doi.org/10.21037/tau-21-820

Ejemplares similares